← Back to Screener
Intuitive Surgical Inc. (ISRG)
Price$458.08
Favorite Metrics
Price vs S&P 500 (26W)0.54%
Price vs S&P 500 (4W)-7.78%
Market Capitalization$164.59B
P/E Ratio (Annual)57.63x
All Metrics
P/CF (Annual)54.31x
Book Value / Share (Quarterly)$50.19
P/TBV (Annual)11.28x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)17.39%
Cash Flow / Share (Quarterly)$7.01
Price vs S&P 500 (YTD)-19.95%
Gross Margin (TTM)66.00%
Net Profit Margin (TTM)28.38%
EPS (TTM)$7.88
10-Day Avg Trading Volume1.69M
EPS Excl Extra (TTM)$7.88
Revenue Growth (5Y)18.22%
EPS (Annual)$7.87
ROI (Annual)16.02%
Gross Margin (Annual)66.00%
Net Profit Margin (5Y Avg)26.51%
Cash / Share (Quarterly)$17.00
P/E Basic Excl Extra (TTM)57.63x
Revenue Growth QoQ (YoY)18.76%
EPS Growth (5Y)21.79%
P/E Normalized (Annual)57.63x
ROA (Last FY)13.96%
Revenue Growth TTM (YoY)20.51%
EBITD / Share (TTM)$8.55
ROE (5Y Avg)13.99%
Operating Margin (TTM)29.27%
Cash Flow / Share (Annual)$7.01
P/B Ratio9.23x
P/B Ratio (Quarterly)11.26x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)16.02x
ROA (TTM)14.43%
EPS Growth QoQ (YoY)17.04%
EV / EBITDA (TTM)51.96x
EPS Incl Extra (Annual)$7.87
Current Ratio (Annual)4.87x
Quick Ratio (Quarterly)3.77x
3-Month Avg Trading Volume1.82M
52-Week Price Return-4.44%
EV / Free Cash Flow (Annual)64.73x
P/E Incl Extra (TTM)57.63x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$50.15
P/S Ratio (Annual)16.35x
Asset Turnover (Annual)0.49x
52-Week High$603.88
Operating Margin (5Y Avg)27.89%
EPS Excl Extra (Annual)$7.87
CapEx CAGR (5Y)9.59%
Tangible BV CAGR (5Y)13.03%
26-Week Price Return4.52%
Quick Ratio (Annual)3.79x
13-Week Price Return-18.23%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.87x
Enterprise Value$161,221.17
Revenue / Share Growth (5Y)18.10%
Asset Turnover (TTM)0.51x
Book Value / Share Growth (5Y)12.74%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)2.06x
Pretax Margin (Annual)32.90%
Cash / Share (Annual)$17.03
3-Month Return Std Dev23.91%
Gross Margin (5Y Avg)67.32%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)18.21%
EBITDA Interim CAGR (5Y)12.34%
ROE (Last FY)16.02%
EPS Basic Excl Extra (Annual)$7.87
P/FCF (TTM)66.08x
Receivables Turnover (TTM)7.31x
EV / Free Cash Flow (TTM)64.73x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$7.88
Receivables Turnover (Annual)7.31x
ROI (TTM)16.36%
P/S Ratio (TTM)16.35x
Pretax Margin (5Y Avg)30.27%
Revenue / Share (Annual)$27.75
Tangible BV / Share (Annual)$50.15
Forward P/E45.84x
Free OCF CAGR (5Y)16.85%
Price vs S&P 500 (52W)-34.27%
P/E Ratio (TTM)57.63x
EPS Growth TTM (YoY)22.81%
Year-to-Date Return-17.30%
5-Day Price Return2.95%
EPS Normalized (Annual)$7.87
ROA (5Y Avg)12.15%
Net Profit Margin (Annual)28.38%
Month-to-Date Return1.60%
Cash Flow / Share (TTM)$5.54
EBITD / Share (Annual)$8.12
EPS Growth (3Y)29.18%
Operating Margin (Annual)29.27%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)54.31x
ROI (5Y Avg)13.99%
P/E Excl Extra (TTM)57.63x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$7.88
P/TBV (Quarterly)11.28x
P/B Ratio (Annual)11.26x
Inventory Turnover (TTM)2.06x
Pretax Margin (TTM)32.90%
Book Value / Share (Annual)$50.19
Price vs S&P 500 (13W)-18.91%
Net Margin Growth (5Y)3.13%
Beta1.59x
P/FCF (Annual)66.08x
Revenue / Share (TTM)$27.93
ROE (TTM)16.36%
52-Week Low$427.84
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.85
3.90
3.90
3.95
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ISRGIntuitive Surgical Inc. | 16.35x | 18.22% | 66.00% | 29.27% | $458.08 |
EWEdwards Lifesciences Corp | 7.42x | 6.70% | 78.01% | 18.41% | $79.05 |
STESTERIS plc | 3.70x | 12.49% | 44.11% | 17.03% | $219.97 |
ZBHZimmer Biomet Holdings, Inc. | 2.28x | 3.22% | 69.71% | 13.34% | $94.78 |
ALGNAlign Technology Inc | 3.29x | 10.30% | 68.27% | 13.53% | $185.02 |
SNNSmith & Nephew plc | 2.36x | 6.21% | 68.01% | 12.88% | $33.83 |
MSAMine Safety Incorporated | 3.40x | 6.82% | 46.46% | 19.83% | $165.17 |
ESTAEstablishment Labs Holdings Inc. | 8.96x | 20.04% | 69.32% | -18.48% | $64.51 |
ENOVEnovis Corporation | 0.65x | -6.05% | 58.16% | -50.09% | $25.20 |
CDRECadre Holdings, Inc. | 2.32x | 8.57% | 42.54% | 11.04% | $30.43 |
AVNSAvanos Medical, Inc. | 1.64x | -0.38% | 50.47% | -8.78% | $24.66 |
About
Intuitive develops and commercializes robotic systems for minimally invasive surgery, along with associated instrumentation, disposable accessories, and support services. The company has deployed over 10,000 da Vinci systems globally, with more than 6,000 installed in the United States and expanding penetration in emerging markets. This installed base generates recurring revenue through consumables and service contracts while positioning Intuitive as a market leader in surgical robotics.